As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

Sidney Braman, MD – (Planner, Moderator, Speaker)
Consultant – Sunovion 
Speaker – Genentech
Independent Contractor – AstraZeneca

Mario Castro, MD – (Speaker)
Consultant – Boston Scientific, Genentech, Teva, Nuvaira, Aviragen, 4D Pharma, VIDA, Neutronic, Mallincrodt, Theravance 
Speaker – Boston Scientific, Genentech, Teva, AstraZeneca, 
Independent Contractor – Sanofi, Boehringer Ingelheim, AstraZeneca, Chiesi, Novartis

Geoffrey Chupp, MD – (Speaker)
Speaker – AstraZeneca, Genentech, Boston Scientific, Circassia
Advisory Board – AstraZeneca, GlaxoSmithKline, Teva

William Corrao, MD – (Moderator, Speaker)
Speaker – Boehringer Ingelheim
Advisory Board – GlaxoSmithKline

James Lamberti, MD – (Speaker)
Speaker – Janssen, Portola, Sunovion, Boehringer Ingelheim
Advisory Board – GlaxoSmithKline, Boehringer Ingelheim

Donald Mahler, MD – (Speaker)
Consultant – Boehringer Ingelheim
Speaker – Boehringer Ingelheim, Sunovion
Advisory Board – Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Sunovion, Theravance

Barry Make, MD – (Speaker)
Consultant – AstraZeneca, GlaxoSmithKline, Circassia, Verona, Third Pole 
Advisory Board – Sunovion

Maria Padilla, MD – (Speaker)
Consultant – Boehringer Ingelheim
Speaker – Genentech

Rey Panettieri Jr., MD – (Planner, Moderator, Speaker)
Speaker – AstraZeneca, MedImmune, Boehringer Ingelheim, Teva 
Advisory Board – AstraZeneca, MedImmune, Novartis, Boehringer Ingelheim,
Independent Contractor – AstraZeneca, Sanofi, MedImmune, Theratrophix, OncoArendi, Vertex, Bristol Myers Squibb, RIFM, Gilead, Genentech

Mary Salvatore, MD – (Speaker)
Speaker – Genentech

Russell Settipane, MD – (Planner, Moderator, Speaker, Reviewer)
Speaker – ALK, AstraZeneca, Boehringer Ingelheim, Circassia, Genentech, Mylan, Pharming, Regeneron, Sanofi, Shire, Sunovion, Teva 
Advisory Board – ALK, AstraZeneca, DBV Technologies, Genentech, Regeneron, Sanofi, Teva, Alk, Circassia, Sanofi/Regeneron, CSL Behring
Independent Contractor – AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Merck, Novartis, Teva

The following have no relevant financial relationships to disclose:
Curtis Sessler, MD – (Speaker)
Lawrence Mohr, MD – (Speaker)
Marilyn Glassberg, MD – (Speaker)